TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Human Vaccines Administered Orally Market, Global Outlook and Forecast 2025-2030

Human Vaccines Administered Orally Market, Global Outlook and Forecast 2025-2030

  • Category:Life Sciences
  • Published on : 03 January 2025
  • Pages :
  • Formats:
  • Report Code:SMR-8026350
OfferClick for best price

Best Price: $2600

Human Vaccines Administered Orally Market Size, Share 2025


Report Overview

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

The global Human Vaccines Administered Orally market size was estimated at USD 1874 million in 2023 and is projected to reach USD 3166.08 million by 2032, exhibiting a CAGR of 6.00% during the forecast period.

North America Human Vaccines Administered Orally market size was estimated at USD 539.83 million in 2023, at a CAGR of 5.14% during the forecast period of 2024 through 2032.

This report provides a deep insight into the global Human Vaccines Administered Orally market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Vaccines Administered Orally Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Vaccines Administered Orally market in any manner.

Global Human Vaccines Administered Orally Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

GSK

Sanofi

Lanzhou Institute

Serum Institute

Valneva

Shanghai United Cell

Bibcol

PaxVax

Vabiotech

Tiantan Biological

EuBiologics

Panacea Biotec Ltd

Bio-Med

Halfkin Bio-Pharmaceuticals

Market Segmentation (by Type)

Rotavirus Vaccine

Cholera Vaccine

Oral Polio Vaccine

Market Segmentation (by Application)

Public

Private

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Human Vaccines Administered Orally Market

Overview of the regional outlook of the Human Vaccines Administered Orally Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Vaccines Administered Orally Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Human Vaccines Administered Orally, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.

Chapter 13 is the main points and conclusions of the report.

Report Attributes Report Details
Report Title Human Vaccines Administered Orally Market, Global Outlook and Forecast 2025-2030
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2024
Forecast Year 2032
Number of Pages NA Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Vaccines Administered Orally
1.2 Key Market Segments
1.2.1 Human Vaccines Administered Orally Segment by Type
1.2.2 Human Vaccines Administered Orally Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Vaccines Administered Orally Market Overview
2.1 Global Market Overview
2.1.1 Global Human Vaccines Administered Orally Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Human Vaccines Administered Orally Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Vaccines Administered Orally Market Competitive Landscape
3.1 Global Human Vaccines Administered Orally Sales by Manufacturers (2019-2024)
3.2 Global Human Vaccines Administered Orally Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Vaccines Administered Orally Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Vaccines Administered Orally Sales Sites, Area Served, Product Type
3.6 Human Vaccines Administered Orally Market Competitive Situation and Trends
3.6.1 Human Vaccines Administered Orally Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Vaccines Administered Orally Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Vaccines Administered Orally Industry Chain Analysis
4.1 Human Vaccines Administered Orally Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Vaccines Administered Orally Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Vaccines Administered Orally Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Vaccines Administered Orally Sales Market Share by Type (2019-2024)
6.3 Global Human Vaccines Administered Orally Market Size Market Share by Type (2019-2024)
6.4 Global Human Vaccines Administered Orally Price by Type (2019-2024)
7 Human Vaccines Administered Orally Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Vaccines Administered Orally Market Sales by Application (2019-2024)
7.3 Global Human Vaccines Administered Orally Market Size (M USD) by Application (2019-2024)
7.4 Global Human Vaccines Administered Orally Sales Growth Rate by Application (2019-2024)
8 Human Vaccines Administered Orally Market Consumption by Region
8.1 Global Human Vaccines Administered Orally Sales by Region
8.1.1 Global Human Vaccines Administered Orally Sales by Region
8.1.2 Global Human Vaccines Administered Orally Sales Market Share by Region
8.2 North America
8.2.1 North America Human Vaccines Administered Orally Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Vaccines Administered Orally Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Vaccines Administered Orally Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Vaccines Administered Orally Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Vaccines Administered Orally Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Human Vaccines Administered Orally Market Production by Region
9.1 Global Production of Human Vaccines Administered Orally by Region (2019-2024)
9.2 Global Human Vaccines Administered Orally Revenue Market Share by Region (2019-2024)
9.3 Global Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Human Vaccines Administered Orally Production
9.4.1 North America Human Vaccines Administered Orally Production Growth Rate (2019-2024)
9.4.2 North America Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Human Vaccines Administered Orally Production
9.5.1 Europe Human Vaccines Administered Orally Production Growth Rate (2019-2024)
9.5.2 Europe Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Human Vaccines Administered Orally Production (2019-2024)
9.6.1 Japan Human Vaccines Administered Orally Production Growth Rate (2019-2024)
9.6.2 Japan Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Human Vaccines Administered Orally Production (2019-2024)
9.7.1 China Human Vaccines Administered Orally Production Growth Rate (2019-2024)
9.7.2 China Human Vaccines Administered Orally Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 Merck
10.1.1 Merck Human Vaccines Administered Orally Basic Information
10.1.2 Merck Human Vaccines Administered Orally Product Overview
10.1.3 Merck Human Vaccines Administered Orally Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck Human Vaccines Administered Orally SWOT Analysis
10.1.6 Merck Recent Developments
10.2 GSK
10.2.1 GSK Human Vaccines Administered Orally Basic Information
10.2.2 GSK Human Vaccines Administered Orally Product Overview
10.2.3 GSK Human Vaccines Administered Orally Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK Human Vaccines Administered Orally SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi
10.3.1 Sanofi Human Vaccines Administered Orally Basic Information
10.3.2 Sanofi Human Vaccines Administered Orally Product Overview
10.3.3 Sanofi Human Vaccines Administered Orally Product Market Performance
10.3.4 Sanofi Human Vaccines Administered Orally SWOT Analysis
10.3.5 Sanofi Business Overview
10.3.6 Sanofi Recent Developments
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Human Vaccines Administered Orally Basic Information
10.4.2 Lanzhou Institute Human Vaccines Administered Orally Product Overview
10.4.3 Lanzhou Institute Human Vaccines Administered Orally Product Market Performance
10.4.4 Lanzhou Institute Business Overview
10.4.5 Lanzhou Institute Recent Developments
10.5 Serum Institute
10.5.1 Serum Institute Human Vaccines Administered Orally Basic Information
10.5.2 Serum Institute Human Vaccines Administered Orally Product Overview
10.5.3 Serum Institute Human Vaccines Administered Orally Product Market Performance
10.5.4 Serum Institute Business Overview
10.5.5 Serum Institute Recent Developments
10.6 Valneva
10.6.1 Valneva Human Vaccines Administered Orally Basic Information
10.6.2 Valneva Human Vaccines Administered Orally Product Overview
10.6.3 Valneva Human Vaccines Administered Orally Product Market Performance
10.6.4 Valneva Business Overview
10.6.5 Valneva Recent Developments
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Human Vaccines Administered Orally Basic Information
10.7.2 Shanghai United Cell Human Vaccines Administered Orally Product Overview
10.7.3 Shanghai United Cell Human Vaccines Administered Orally Product Market Performance
10.7.4 Shanghai United Cell Business Overview
10.7.5 Shanghai United Cell Recent Developments
10.8 Bibcol
10.8.1 Bibcol Human Vaccines Administered Orally Basic Information
10.8.2 Bibcol Human Vaccines Administered Orally Product Overview
10.8.3 Bibcol Human Vaccines Administered Orally Product Market Performance
10.8.4 Bibcol Business Overview
10.8.5 Bibcol Recent Developments
10.9 PaxVax
10.9.1 PaxVax Human Vaccines Administered Orally Basic Information
10.9.2 PaxVax Human Vaccines Administered Orally Product Overview
10.9.3 PaxVax Human Vaccines Administered Orally Product Market Performance
10.9.4 PaxVax Business Overview
10.9.5 PaxVax Recent Developments
10.10 Vabiotech
10.10.1 Vabiotech Human Vaccines Administered Orally Basic Information
10.10.2 Vabiotech Human Vaccines Administered Orally Product Overview
10.10.3 Vabiotech Human Vaccines Administered Orally Product Market Performance
10.10.4 Vabiotech Business Overview
10.10.5 Vabiotech Recent Developments
10.11 Tiantan Biological
10.11.1 Tiantan Biological Human Vaccines Administered Orally Basic Information
10.11.2 Tiantan Biological Human Vaccines Administered Orally Product Overview
10.11.3 Tiantan Biological Human Vaccines Administered Orally Product Market Performance
10.11.4 Tiantan Biological Business Overview
10.11.5 Tiantan Biological Recent Developments
10.12 EuBiologics
10.12.1 EuBiologics Human Vaccines Administered Orally Basic Information
10.12.2 EuBiologics Human Vaccines Administered Orally Product Overview
10.12.3 EuBiologics Human Vaccines Administered Orally Product Market Performance
10.12.4 EuBiologics Business Overview
10.12.5 EuBiologics Recent Developments
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Human Vaccines Administered Orally Basic Information
10.13.2 Panacea Biotec Ltd Human Vaccines Administered Orally Product Overview
10.13.3 Panacea Biotec Ltd Human Vaccines Administered Orally Product Market Performance
10.13.4 Panacea Biotec Ltd Business Overview
10.13.5 Panacea Biotec Ltd Recent Developments
10.14 Bio-Med
10.14.1 Bio-Med Human Vaccines Administered Orally Basic Information
10.14.2 Bio-Med Human Vaccines Administered Orally Product Overview
10.14.3 Bio-Med Human Vaccines Administered Orally Product Market Performance
10.14.4 Bio-Med Business Overview
10.14.5 Bio-Med Recent Developments
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Basic Information
10.15.2 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Overview
10.15.3 Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Market Performance
10.15.4 Halfkin Bio-Pharmaceuticals Business Overview
10.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 Human Vaccines Administered Orally Market Forecast by Region
11.1 Global Human Vaccines Administered Orally Market Size Forecast
11.2 Global Human Vaccines Administered Orally Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Human Vaccines Administered Orally Market Size Forecast by Country
11.2.3 Asia Pacific Human Vaccines Administered Orally Market Size Forecast by Region
11.2.4 South America Human Vaccines Administered Orally Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Human Vaccines Administered Orally by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Human Vaccines Administered Orally Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Human Vaccines Administered Orally by Type (2025-2032)
12.1.2 Global Human Vaccines Administered Orally Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Human Vaccines Administered Orally by Type (2025-2032)
12.2 Global Human Vaccines Administered Orally Market Forecast by Application (2025-2032)
12.2.1 Global Human Vaccines Administered Orally Sales (K MT) Forecast by Application
12.2.2 Global Human Vaccines Administered Orally Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Vaccines Administered Orally Market Size Comparison by Region (M USD)
Table 5. Global Human Vaccines Administered Orally Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Human Vaccines Administered Orally Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Vaccines Administered Orally Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Vaccines Administered Orally Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Vaccines Administered Orally as of 2022)
Table 10. Global Market Human Vaccines Administered Orally Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Vaccines Administered Orally Sales Sites and Area Served
Table 12. Manufacturers Human Vaccines Administered Orally Product Type
Table 13. Global Human Vaccines Administered Orally Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Vaccines Administered Orally
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Vaccines Administered Orally Market Challenges
Table 22. Global Human Vaccines Administered Orally Sales by Type (K MT)
Table 23. Global Human Vaccines Administered Orally Market Size by Type (M USD)
Table 24. Global Human Vaccines Administered Orally Sales (K MT) by Type (2019-2024)
Table 25. Global Human Vaccines Administered Orally Sales Market Share by Type (2019-2024)
Table 26. Global Human Vaccines Administered Orally Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Vaccines Administered Orally Market Size Share by Type (2019-2024)
Table 28. Global Human Vaccines Administered Orally Price (USD/MT) by Type (2019-2024)
Table 29. Global Human Vaccines Administered Orally Sales (K MT) by Application
Table 30. Global Human Vaccines Administered Orally Market Size by Application
Table 31. Global Human Vaccines Administered Orally Sales by Application (2019-2024) & (K MT)
Table 32. Global Human Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Table 33. Global Human Vaccines Administered Orally Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Vaccines Administered Orally Market Share by Application (2019-2024)
Table 35. Global Human Vaccines Administered Orally Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Vaccines Administered Orally Sales by Region (2019-2024) & (K MT)
Table 37. Global Human Vaccines Administered Orally Sales Market Share by Region (2019-2024)
Table 38. North America Human Vaccines Administered Orally Sales by Country (2019-2024) & (K MT)
Table 39. Europe Human Vaccines Administered Orally Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Human Vaccines Administered Orally Sales by Region (2019-2024) & (K MT)
Table 41. South America Human Vaccines Administered Orally Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Human Vaccines Administered Orally Sales by Region (2019-2024) & (K MT)
Table 43. Global Human Vaccines Administered Orally Production (K MT) by Region (2019-2024)
Table 44. Global Human Vaccines Administered Orally Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Human Vaccines Administered Orally Revenue Market Share by Region (2019-2024)
Table 46. Global Human Vaccines Administered Orally Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Human Vaccines Administered Orally Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Human Vaccines Administered Orally Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Human Vaccines Administered Orally Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Human Vaccines Administered Orally Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Merck Human Vaccines Administered Orally Basic Information
Table 52. Merck Human Vaccines Administered Orally Product Overview
Table 53. Merck Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Merck Business Overview
Table 55. Merck Human Vaccines Administered Orally SWOT Analysis
Table 56. Merck Recent Developments
Table 57. GSK Human Vaccines Administered Orally Basic Information
Table 58. GSK Human Vaccines Administered Orally Product Overview
Table 59. GSK Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. GSK Business Overview
Table 61. GSK Human Vaccines Administered Orally SWOT Analysis
Table 62. GSK Recent Developments
Table 63. Sanofi Human Vaccines Administered Orally Basic Information
Table 64. Sanofi Human Vaccines Administered Orally Product Overview
Table 65. Sanofi Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Sanofi Human Vaccines Administered Orally SWOT Analysis
Table 67. Sanofi Business Overview
Table 68. Sanofi Recent Developments
Table 69. Lanzhou Institute Human Vaccines Administered Orally Basic Information
Table 70. Lanzhou Institute Human Vaccines Administered Orally Product Overview
Table 71. Lanzhou Institute Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Lanzhou Institute Business Overview
Table 73. Lanzhou Institute Recent Developments
Table 74. Serum Institute Human Vaccines Administered Orally Basic Information
Table 75. Serum Institute Human Vaccines Administered Orally Product Overview
Table 76. Serum Institute Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Serum Institute Business Overview
Table 78. Serum Institute Recent Developments
Table 79. Valneva Human Vaccines Administered Orally Basic Information
Table 80. Valneva Human Vaccines Administered Orally Product Overview
Table 81. Valneva Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Valneva Business Overview
Table 83. Valneva Recent Developments
Table 84. Shanghai United Cell Human Vaccines Administered Orally Basic Information
Table 85. Shanghai United Cell Human Vaccines Administered Orally Product Overview
Table 86. Shanghai United Cell Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Shanghai United Cell Business Overview
Table 88. Shanghai United Cell Recent Developments
Table 89. Bibcol Human Vaccines Administered Orally Basic Information
Table 90. Bibcol Human Vaccines Administered Orally Product Overview
Table 91. Bibcol Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Bibcol Business Overview
Table 93. Bibcol Recent Developments
Table 94. PaxVax Human Vaccines Administered Orally Basic Information
Table 95. PaxVax Human Vaccines Administered Orally Product Overview
Table 96. PaxVax Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. PaxVax Business Overview
Table 98. PaxVax Recent Developments
Table 99. Vabiotech Human Vaccines Administered Orally Basic Information
Table 100. Vabiotech Human Vaccines Administered Orally Product Overview
Table 101. Vabiotech Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Vabiotech Business Overview
Table 103. Vabiotech Recent Developments
Table 104. Tiantan Biological Human Vaccines Administered Orally Basic Information
Table 105. Tiantan Biological Human Vaccines Administered Orally Product Overview
Table 106. Tiantan Biological Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Tiantan Biological Business Overview
Table 108. Tiantan Biological Recent Developments
Table 109. EuBiologics Human Vaccines Administered Orally Basic Information
Table 110. EuBiologics Human Vaccines Administered Orally Product Overview
Table 111. EuBiologics Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. EuBiologics Business Overview
Table 113. EuBiologics Recent Developments
Table 114. Panacea Biotec Ltd Human Vaccines Administered Orally Basic Information
Table 115. Panacea Biotec Ltd Human Vaccines Administered Orally Product Overview
Table 116. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Panacea Biotec Ltd Business Overview
Table 118. Panacea Biotec Ltd Recent Developments
Table 119. Bio-Med Human Vaccines Administered Orally Basic Information
Table 120. Bio-Med Human Vaccines Administered Orally Product Overview
Table 121. Bio-Med Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Bio-Med Business Overview
Table 123. Bio-Med Recent Developments
Table 124. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Basic Information
Table 125. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Overview
Table 126. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Halfkin Bio-Pharmaceuticals Business Overview
Table 128. Halfkin Bio-Pharmaceuticals Recent Developments
Table 129. Global Human Vaccines Administered Orally Sales Forecast by Region (2025-2032) & (K MT)
Table 130. Global Human Vaccines Administered Orally Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Human Vaccines Administered Orally Sales Forecast by Country (2025-2032) & (K MT)
Table 132. North America Human Vaccines Administered Orally Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Human Vaccines Administered Orally Sales Forecast by Country (2025-2032) & (K MT)
Table 134. Europe Human Vaccines Administered Orally Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Human Vaccines Administered Orally Sales Forecast by Region (2025-2032) & (K MT)
Table 136. Asia Pacific Human Vaccines Administered Orally Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Human Vaccines Administered Orally Sales Forecast by Country (2025-2032) & (K MT)
Table 138. South America Human Vaccines Administered Orally Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Human Vaccines Administered Orally Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Human Vaccines Administered Orally Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Human Vaccines Administered Orally Sales Forecast by Type (2025-2032) & (K MT)
Table 142. Global Human Vaccines Administered Orally Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Human Vaccines Administered Orally Price Forecast by Type (2025-2032) & (USD/MT)
Table 144. Global Human Vaccines Administered Orally Sales (K MT) Forecast by Application (2025-2032)
Table 145. Global Human Vaccines Administered Orally Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Human Vaccines Administered Orally
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Vaccines Administered Orally Market Size (M USD), 2019-2032
Figure 5. Global Human Vaccines Administered Orally Market Size (M USD) (2019-2032)
Figure 6. Global Human Vaccines Administered Orally Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Vaccines Administered Orally Market Size by Country (M USD)
Figure 11. Human Vaccines Administered Orally Sales Share by Manufacturers in 2023
Figure 12. Global Human Vaccines Administered Orally Revenue Share by Manufacturers in 2023
Figure 13. Human Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Vaccines Administered Orally Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Vaccines Administered Orally Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Vaccines Administered Orally Market Share by Type
Figure 18. Sales Market Share of Human Vaccines Administered Orally by Type (2019-2024)
Figure 19. Sales Market Share of Human Vaccines Administered Orally by Type in 2023
Figure 20. Market Size Share of Human Vaccines Administered Orally by Type (2019-2024)
Figure 21. Market Size Market Share of Human Vaccines Administered Orally by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Vaccines Administered Orally Market Share by Application
Figure 24. Global Human Vaccines Administered Orally Sales Market Share by Application (2019-2024)
Figure 25. Global Human Vaccines Administered Orally Sales Market Share by Application in 2023
Figure 26. Global Human Vaccines Administered Orally Market Share by Application (2019-2024)
Figure 27. Global Human Vaccines Administered Orally Market Share by Application in 2023
Figure 28. Global Human Vaccines Administered Orally Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Vaccines Administered Orally Sales Market Share by Region (2019-2024)
Figure 30. North America Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Human Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 32. U.S. Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Human Vaccines Administered Orally Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Human Vaccines Administered Orally Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Human Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 37. Germany Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Human Vaccines Administered Orally Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Human Vaccines Administered Orally Sales Market Share by Region in 2023
Figure 44. China Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Human Vaccines Administered Orally Sales and Growth Rate (K MT)
Figure 50. South America Human Vaccines Administered Orally Sales Market Share by Country in 2023
Figure 51. Brazil Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Human Vaccines Administered Orally Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Human Vaccines Administered Orally Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Human Vaccines Administered Orally Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Human Vaccines Administered Orally Production Market Share by Region (2019-2024)
Figure 62. North America Human Vaccines Administered Orally Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Human Vaccines Administered Orally Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Human Vaccines Administered Orally Production (K MT) Growth Rate (2019-2024)
Figure 65. China Human Vaccines Administered Orally Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Human Vaccines Administered Orally Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Human Vaccines Administered Orally Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Human Vaccines Administered Orally Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Human Vaccines Administered Orally Market Share Forecast by Type (2025-2032)
Figure 70. Global Human Vaccines Administered Orally Sales Forecast by Application (2025-2032)
Figure 71. Global Human Vaccines Administered Orally Market Share Forecast by Application (2025-2032)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount